Tuesday, March 22, 2022
IT Executive Scott Stefan Appointed Assistant Dean and Deputy Chief Information Officer at University of Maryland School of Medicine
University of Maryland School of Medicine (UMSOM) Associate Dean and Chief Information Officer (CIO) Sharon Bowser, MB, along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Scott Stefan, MBA, an information technology executive and veteran of the UMSOM’s Office of Information Technology, has been appointed Assistant Dean and Deputy CIO, effective immediately.
Wednesday, March 16, 2022
Two University of Maryland School of Medicine Women Faculty Leaders Featured in New Book
Dr. Kathleen Neuzil and Dr. Donna L. Parker are Two of 33 Women Included in Case Studies Featured in Lessons Learned: Stories from Women Physician Leaders
Wednesday, March 16, 2022
University of Maryland School of Medicine Announces New Integrated Model for UM Faculty Physicians, Inc. (FPI), Positions for Accelerated, Long-Term Business Growth and Success
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, has appointed new interim leadership for University of Maryland Faculty Physicians, Inc. (FPI), as part of a new FPI integrated model that has been designed for over a year.
Monday, March 14, 2022
Dancing Laboratory Rats Show How the Brain Learns, Perfects, then Unconsciously Performs a Skillful Movement
Learning a complex skilled movement like tying your shoes or playing an instrument takes practice. After repeating the same movements over and over, people often develop a formulaic way of performing the task, and may not even have to think about it anymore. Although we accomplish such repetitive tasks every day, little is known about how the brain learns, repeats, and perfects them.
Monday, March 14, 2022
UMSOM Transplant Surgeon Performs Maryland's First Robot-Assisted Living Donor Kidney Transplant
Innovative Surgery Performed at the University of Maryland Medical Center Promises Reduced Hospital Stay and New Options for Obese Patients
Wednesday, March 09, 2022
IN MEMORIAM: David Bennett, Sr.
David Bennett, the 57 year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yesterday on March 8. Mr. Bennett received the transplant on January 7 and lived for two months following the surgery. His condition began deteriorating several days ago. After it became clear that he would not recover, he was given compassionate palliative care. He was able to communicate with his family during his final hours.
Monday, March 07, 2022
Financial Strain Linked to Increased Risk of Death in Older Adults Recovering from Heart Attack, UM School of Medicine Study Finds
Older adults who report being under severe financial strain were substantially more likely to die within six months of having a heart attack compared to those with moderate or no financial strain, according to a new study led by University of Maryland School of Medicine (UMSOM) researchers. Findings were published last week in the JAMA Internal Medicine and point to glaring disparities in medical outcomes due to financial circumstances.
Monday, February 28, 2022
UM School of Medicine Research Leads to Innovative Non-Invasive Treatment for Parkinson’s Disease at UM Medical Center
– A non-invasive ultrasound treatment for Parkinson’s disease that was tested in a pivotal trial led by University of Maryland School of Medicine (UMSOM) researchers is now broadly available at the University of Maryland Medical Center (UMMC). The device, called Exablate Neuro, was approved in November by the US Food and Drug Administration to treat advanced Parkinson’s disease on one side of the brain.
Wednesday, February 16, 2022
Study Shows New Drug Combination More Effective Against SARS-CoV-2
Researchers at the University of Maryland School of Medicine (UMSOM) and University of Pennsylvania Perelman School of Medicine have identified a powerful combination of antivirals to treat COVID-19. The researchers showed that combining the experimental drug brequinar with either of the two drugs already approved by the U.S. Food and Drug Administration for emergency use, remdesivir or molnupiravir, inhibited growth of the SARS-CoV-2 virus in human lung cells and in mice. Their findings suggest that these drugs are more potent when used in combination than individually.
Tuesday, February 15, 2022
UM School of Medicine Awarded $1.87 Million Grant to Increase Diversity in Genetic Counseling Programs
University of Maryland School of Medicine (UMSOM) faculty members in the Master’s in Genetic Counseling (MGC) Training Program have been awarded a $1.87 million grant from the Warren Alpert Foundation (WAF) to recruit and retain genetic counseling students from diverse backgrounds, both at the level of incoming students and as practicing genetic counselors.